It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: TheAMEDDDoc
a reply to: Advantage
A healthy person will not get reinfected or however they’re putting it, the whole point of producing antibodies is to create an adaptive response that the body will remember through memory T and B cells.
If a person has underlying chronic disease and this thing goes latent or systemic then it could overwhelm the host but they’re going to be fighting multiple pathogens in addition to this thing. Immunocompromised patients are unable to overcome the drop in white blood cells and neutrophils that occurs with viral infections so they may appear to improve then go down. They are also more prone to the pneumonia type infections and going into septic shock as it goes systemic.
From what I’m hearing from people studying this and who work with similar pathogens, if you’re healthy it’s going to be an annoying nasty cold at the most and this thing is here to stay. They’re not worried at all, their concern is poor nations and immunocompromised or immunosuppressed patients. That’s the target population of the upcoming vaccine, plus the very young and very old because they are more vulnerable. Kids may also be the primary spreaders of a disease like this with very mild symptoms.
Severe viral infections can also cause neurological problems post infection similar to what we see with vaccines but those should resolve with time. Rare cases can cross to the brain or other organs in systemic patients, very unlikely in a healthy or average person.
Our study rejects the hypothesis of emergence as a result of a recent recombination event. Notably, the new coronavirus provides a new lineage for almost half of its genome, with no close genetic relationships to other viruses within the subgenus of sarbecovirus. This genomic part comprises half of the spike region encoding a multifunctional protein responsible also for virus entry into host cells (Babcock et al., 2004; Li et al., 2005b). The unique genetic features of 2019-nCoV and their potential association with virus characteristics and virulence in humans remain to be elucidated.
originally posted by: all2human
a reply to: ketsuko
Secondary infection may not be the case at all
hasn't been well explained
but i'm assuming(non-expert opinion) it's the virus either circulating from bone marrow or the brain ( heard this crosses the blood brain barrier some time ago)
A secondary case could also be a legitimate re-infection,but to a host with gained immunity
Happens.
The big worry is if we all get it at once,people get turned away
But most will come down with a bad cold,flu like symptoms
I think i read 17% will require hospitalization,which is not good considering the above
Over 80%, some statistics show much more depending on age
a bad cold..
I'm not moving to the mountains,eating squirrel and tree bark over this
just to come down 2 years later with the sniffles.
3 employees of Chongqing Taiye Co. infected with #COVID19 after reopen, over 100 employees qurantined. Production stopped altogether.
In Nantong City, Jiangsu Province, a family forcibly taken away by people in protective suits
800 employees of SK Hynix Inc. in South Korea quarantined after one found to have symptoms of #wuhanpneumonia #COVID2019 #Coronavirus #CoronavirusOutbreak
We show evidence that the novel coronavirus (2019-nCov) is not-mosaic consisting in almost half of its genome of a distinct lineage within the betacoronavirus.
originally posted by: pasiphae
I guess I'm the only one thinking about Iran getting hit really hard right now? I looked up Tehran and it is a lot like Wuhan. Very similar population density and bad air pollution. Looks like it's probable that 20 people have died in Iran (9 reported). This may blow up in Iran pretty bad in the next couple of weeks.
originally posted by: tgidkp
a reply to: FamCore
so, this paper gives a third option to ketsuko's (inaccurate) analysis:...
it says that the viral REinfection occurs because after the initial infection, and after the body has successfully produced it's antibodies, the virus can come back in and attack the immune system directly by using the antibodies to mediate entry into the immunoglobulin cells.... thus disabling the body's immunity to the virus and allowing the viral infection to penetrate more deeply the second time around.
i had never heard of this, and it is an excellent explanation of why viral REinfection is more deadly than the initial infection.
(also a great example of why people (ketsuko) whom dont understand the science should not state so definitively on the technical aspects.)
originally posted by: ketsuko
a reply to: FamCore
We show evidence that the novel coronavirus (2019-nCov) is not-mosaic consisting in almost half of its genome of a distinct lineage within the betacoronavirus.
Husband is saying that the use of the term "not-mosaic" means it's not engineered. So what they're concluding is that they don't know where parts of it come from for sure, but that 96% comes from the bat strain, and that it's not showing signs of being engineered wherever the rest of it came from.